Antithrombotic therapy after transcatheter aortic valve replacement

Antithrombotic therapy after transcatheter aortic valve replacement

Transcatheter aortic valve replacement (TAVR) is a treatment option for patients with asymptomatic severe aortic stenosis who are candidates for a bioprosthesis across the entire spectrum of risk. TAVR carries a risk for thrombotic and bleeding events, focusing on the importance of defining the opti...

Full description

Bibliographic Details
Main Authors: Tariq A.M. Mousa, Ahmed Mahfouz, Nazar Mohammed
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Heart Views
Subjects:
antiplatelet
antithrombotic
dual-antiplatelet therapy
new oral anticoagulant
oral anticoagulants
transcatheter aortic valve replacement
vitamin k antagonists
Online Access:http://www.heartviews.org/article.asp?issn=1995-705X;year=2022;volume=23;issue=1;spage=10;epage=15;aulast=Mousa

Internet

http://www.heartviews.org/article.asp?issn=1995-705X;year=2022;volume=23;issue=1;spage=10;epage=15;aulast=Mousa

Similar Items